Drug intelligence / Profile preview

UltraSlice

Development stage
Preclinical
Lead developer
Factor Bioscience
Modality
Recombinant Proteins and Enzymes, Cell Therapies, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Gene Therapies
Administration
Ex Vivo
01

Overview

UltraSlice is a gene-editing protein technology platform developed by Factor Bioscience. It utilizes mRNA-based delivery to express gene-editing proteins for efficient and precise transgene insertion into the genome, specifically targeting sites like the TRAC locus in primary human T cells and induced pluripotent stem cells (iPSCs). The platform is designed to support the development of next-generation cell therapies, including allogeneic CAR-T cells, for applications in oncology, autoimmune diseases, and rare diseases. To enhance performance, the technology incorporates modified nucleotides, such as 5-methoxyuridine, which reduce immunogenicity and improve editing efficiency while maintaining high cell viability.

Brand names
UltraSlice
02

Targets

gDNA (Genomic DNA at specified editing loci)TCR (T cell antigen receptor complex)

Beyond the preview

Go deeper on UltraSlice.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UltraSlice.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call